High-affinity recognition of HIV-1 frameshift-stimulating RNA alters frameshifting in vitro and interferes with HIV-1 infectivity

Journal of Medicinal Chemistry

Volumn 57, Issue 3, 2014, Pages 723-732

  Ofori, Leslie O ^a   Hilimire, Thomas A ^b   Bennett, Ryan P ^c   Brown, Nathaniel W ^a   Smith, Harold C ^b,c   Miller, Benjamin L ^a,b  

^a UNIVERSITY OF ROCHESTER   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c OyaGen Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI-HIV AGENTS; CELL MEMBRANE PERMEABILITY; CELL SURVIVAL; DISULFIDES; FRAMESHIFTING, RIBOSOMAL; HEK293 CELLS; HIV-1; HUMANS; LUCIFERASES, FIREFLY; LUCIFERASES, RENILLA; NUCLEIC ACID CONFORMATION; QUINOLINES; RNA, VIRAL; STEREOISOMERISM; VIRION; VIRUS REPLICATION;

EID: 84894062678     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm401438g     Document Type: Article

References (53)

1. Fauci, A. S. The human immunodeficiency virus: infectivity and mechanisms of pathogenesis Science 1988, 239, 617-622
2. Guyader, M.; Emerman, M.; Sonigo, P.; Clavel, F.; Montagnier, L.; Alizon, M. Genome organization and transactivation of the human immunodeficiency virus type 2 Nature 1987, 326, 662-669
3. unaids.org/documents/20101123-GlobalReport-Chap2-em.pdf.
4. Bangsberg, D. R.; Perry, S.; Charlebois, E. D.; Clark, R. A.; Roberston, M.; Zolopa, A. R.; Moss, A. Non-adherence to highly active antiretroviral therapy predicts progression to AIDS AIDS 2001, 15, 1181-1183
5. Saini, S. S.; Bhalla, P. P.; Gautam, H. H.; Baveja, U. K. U.; Pasha, S. T. S.; Dewan, R. R. Resistance-Associated Mutations in HIV-1 among Patients Failing First-Line Antiretroviral Therapy J. Int. Assoc. Physicians AIDS Care 1970, 11, 203-209
6. Brakier-Gingras, L.; Charbonneau, J.; Butcher, S. E. Targeting frameshifting in the human immunodeficiency virus Expert Opin. Ther. Targets 2012, 249-258
7. Dulude, D.; Berchiche, Y. A.; Gendron, K.; Brakier-Gingras, L.; Heveker, N. Decreasing the frameshift efficiency translates into an equivalent reduction of the replication of the human immunodeficiency virus type 1 Virology 2006, 345, 127-136
8. Dulude, D.; Baril, M.; Brakier-Gingras, L. Characterization of the frameshift stimulatory signal controlling a programmed -1 ribosomal frameshift in the human immunodeficiency virus type 1 Nucleic Acids Res. 2002, 30, 5094-5102
9. Brakier-Gingras, L.; Dulude, D. Programmed -1 ribosomal frameshift in the human immunodeficiency virus of type 1. In Recoding: Expansion of Decoding Rules Enriches Gene Expression; Atkins, J.; Gesteland, R., Eds.; Springer: New York, NY, 2010; pp 175-192.
10. Weiss, R. B. R.; Dunn, D. M. D.; Shuh, M. M.; Atkins, J. F. J.; Gesteland, R. F. R. E. coli ribosomes re-phase on retroviral frameshift signals at rates ranging from 2 to 50% New Biol. 1989, 1, 159-169
11. Namy, O.; Moran, S. J.; Stuart, D. I.; Gilbert, R. J. C.; Brierley, I. A mechanical explanation of RNA pseudoknot function in programmed ribosomal frameshifting Nature 2006, 441, 244-247
12. Léger, M.; Dulude, D.; Steinberg, S. V.; Brakier-Gingras, L. The three transfer RNAs occupying the A, P and E sites on the ribosome are involved in viral programmed -1 ribosomal frameshift Nucleic Acids Res. 2007, 35, 5581-5592
13. Telenti, A. A.; Martinez, R. R.; Munoz, M. M.; Bleiber, G. G.; Greub, G. G.; Sanglard, D. D.; Peters, S. S. Analysis of natural variants of the human immunodeficiency virus type 1 gag-pol frameshift stem-loop structure J. Virol. 2002, 76, 7868-7873
14. Brierley, I.; Pennell, S. Structure and Function of the Stimulatory RNAs Involved in Programmed Eukaryotic -1 Ribosomal Frameshifting Cold Spring Harbor Symp. Quant. Biol. 2001, 66, 233-248
15. Irvine, J. H. J.; Horsfield, J. A. J.; McKinney, C. Z. C.; Tate, W. P. W. A novel strategy to interfere with human immunodeficiency virus type 1 propagation N. Z. Med. J. 1998, 111, 222-224
16. Kinzy, T. G. New Targets for Antivirals: The Ribosomal A-Site and the Factors That Interact with It Virology 2002, 300, 60-70
17. Kobayashi, Y.; Zhuang, J.; Peltz, S.; Dougherty, J. Identification of a cellular factor that modulates HIV-1 programmed ribosomal frameshifting J. Biol. Chem. 2010, 285, 19776-19784
18. Staple, D. W.; Butcher, S. E. Solution structure of the HIV-1 frameshift inducing stem-loop RNA Nucleic Acids Res. 2003, 31, 4326-4331
19. Staple, D. W.; Butcher, S. E. Solution structure and thermodynamic investigation of the HIV-1 frameshift inducing element J. Mol. Biol. 2005, 349, 1011-1023
20. Gaudin, C.; Mazauric, M.-H.; Traïkia, M.; Guittet, E.; Yoshizawa, S.; Fourmy, D. Structure of the RNA Signal Essential for Translational Frameshifting in HIV-1 J. Mol. Biol. 2005, 349, 1024-1035
21. Sorin, E. J.; Engelhardt, M. A.; Herschlag, D.; Pande, V. S. RNA simulations: probing hairpin unfolding and the dynamics of a GNRA tetraloop J. Mol. Biol. 2002, 317, 493-506
22. Watts, J. M.; Dang, K. K.; Gorelick, R. J.; Leonard, C. W.; Bess, J. W.; Swanstrom, R.; Burch, C. L.; Weeks, K. M. Architecture and secondary structure of an entire HIV-1 RNA genome Nature 2009, 460, 711-716
23. Low, J. T.; Weeks, K. M. SHAPE-directed RNA secondary structure prediction Methods 2010, 52, 150-158
24. Brierley, I.; Ramos Dos, F. J. Programmed ribosomal frameshifting in HIV-1 and the SARS-CoV Virus Res. 2006, 119, 29-42
25. Kim, Y. G. Y.; Maas, S. S.; Rich, A. A. Comparative mutational analysis of cis-acting RNA signals for translational frameshifting in HIV-1 and HTLV-2 Nucleic Acids Res. 2001, 29, 1125-1131
26. Falk, H. H.; Mador, N. N.; Udi, R. R.; Panet, A. A.; Honigman, A. A. Two cis-acting signals control ribosomal frameshift between human T-cell leukemia virus type II gag and pro genes J. Virol. 1993, 67, 6273-6277
27. Hung, M.; Patel, P.; Davis, S.; Green, S. R. Importance of ribosomal frameshifting for human immunodeficiency virus type 1 particle assembly and replication J. Virol. 1998, 72, 4819-4824
28. Babé, L. M.; Craik, C. S. Constitutive production of nonenveloped human immunodeficiency virus type 1 particles by a mammalian cell line and effects of a protease inhibitor on particle maturation Antimicrob. Agents Chemother. 1994, 38, 2430-2439
29. Marcheschi, R. J.; Tonelli, M.; Kumar, A.; Butcher, S. E. Structure of the HIV-1 frameshift site RNA bound to a small molecule inhibitor of viral replication ACS Chem. Biol. 2011, 6, 857-864
30. Staple, D. W.; Venditti, V.; Niccolai, N.; Elson-Schwab, L.; Tor, Y.; Butcher, S. E. Guanidinoneomycin B recognition of an HIV-1 RNA helix ChemBioChem 2008, 9, 93-102
31. Marcheschi, R. J.; Mouzakis, K. D.; Butcher, S. E. Selection and characterization of small molecules that bind the HIV-1 frameshift site RNA ACS Chem. Biol. 2009, 4, 844-854
32. Dulude, D.; Théberge-Julien, G.; Brakier-Gingras, L.; Heveker, N. Selection of peptides interfering with a ribosomal frameshift in the human immunodeficiency virus type 1 RNA 2008, 14, 981-991
33. Karan, C. C.; Miller, B. L. B. RNA-selective coordination complexes identified via dynamic combinatorial chemistry J. Am. Chem. Soc. 2001, 123, 7455-7456
34. McNaughton, B. R.; Miller, B. L. Resin-bound dynamic combinatorial chemistry Org. Lett. 2006, 8, 1803-1806
35. Palde, P. B.; Ofori, L. O.; Gareiss, P. C.; Lerea, J.; Miller, B. L. Strategies for recognition of stem-loop RNA structures by synthetic ligands: application to the HIV-1 frameshift stimulatory sequence J. Med. Chem. 2010, 53, 6018-6027
36. McNaughton, B. R.; Gareiss, P. C.; Miller, B. L. Identification of a Selective Small-Molecule Ligand for HIV-1 Frameshift-Inducing Stem-Loop RNA from an 11,325 Member Resin Bound Dynamic Combinatorial Library J. Am. Chem. Soc. 2007, 129, 11306-11307
37. Ofori, L. O.; Hoskins, J.; Nakamori, M.; Thornton, C. A.; Miller, B. L. From dynamic combinatorial "hit" to lead: in vitro and in vivo activity of compounds targeting the pathogenic RNAs that cause myotonic dystrophy Nucleic Acids Res. 2012, 40, 6380-6390
38. Davis, T. M.; Wilson, W. D. Surface plasmon resonance biosensor analysis of RNA-small molecule interactions Meth. Enzymol. 2001, 340, 22-51
39. Rich, R. L.; Myszka, D. G. Survey of the 2009 commercial optical biosensor literature J. Mol. Recognit. 2011, 24, 892-914
40. Giannetti, A. M.; Koch, B. D.; Browner, M. F. Surface plasmon resonance based assay for the detection and characterization of promiscuous inhibitors J. Med. Chem. 2008, 51, 574-580
41. Luedtke, N. W.; Carmichael, P.; Tor, Y. Cellular uptake of aminoglycosides, guanidinoglycosides, and poly-arginine J. Am. Chem. Soc. 2003, 125, 12374-12375
42. Buttke, T. M. T.; McCubrey, J. A. J.; Owen, T. C. T. Use of an aqueous soluble tetrazolium/formazan assay to measure viability and proliferation of lymphokine-dependent cell lines J. Immunol. Methods 1993, 157, 233-240
43. Grentzmann, G.; Ingram, J. A.; Kelly, P. J.; Gesteland, R. F.; Atkins, J. F. A dual-luciferase reporter system for studying recoding signals RNA 1998, 4, 479-486
44. Falk, H. H.; Mador, N. N.; Udi, R. R.; Panet, A. A.; Honigman, A. A. Two cis-acting signals control ribosomal frameshift between human T-cell leukemia virus type II gag and pro genes J. Virol. 1993, 67, 6273-6277
45. Kim, Y. G. Y.; Maas, S. S.; Rich, A. A. Comparative mutational analysis of cis-acting RNA signals for translational frameshifting in HIV-1 and HTLV-2 Nucleic Acids Res. 2001, 29, 1125-1131
46. Miller, J. H.; Presnyak, V.; Smith, H. C. The dimerization domain of HIV-1 viral infectivity factor Vif is required to block virion incorporation of APOBEC3G Retrovirology 2007, 4, 81
47. Zhang, L.; Gorset, W.; Washington, C. B.; Blaschke, T. F.; Kroetz, D. L.; Giacomini, K. M. Interactions of HIV protease inhibitors with a human organic cation transporter in a mammalian expression system Drug Metab. Dispos. 2000, 28, 329-334
48. Guan, L.; Disney, M. D. Recent advances in developing small molecules targeting RNA ACS Chem. Biol. 2012, 7, 73-86
49. Thomas, J. R.; Hergenrother, P. J. Targeting RNA with Small Molecules Chem. Rev. 2008, 108, 1171-1224
50. Kumar, S. S.; Kellish, P. P.; Robinson, W. E. W.; Wang, D. D.; Appella, D. H. D.; Arya, D. P. D. Click dimers to target HIV TAR RNA conformation Biochemistry 2012, 51, 2331-2347
51. Thomas, J. R. J.; Liu, X. X.; Hergenrother, P. J. P. Size-specific ligands for RNA hairpin loops J. Am. Chem. Soc. 2005, 127, 12434-12435
52. Shehu-Xhilaga, M.; Crowe, S. M.; Mak, J. Maintenance of the Gag/Gag-Pol ratio is important for human immunodeficiency virus type 1 RNA dimerization and viral infectivity J. Virol. 2001, 75, 1834-1841
53. Platt, E. J. E.; Wehrly, K. K.; Kuhmann, S. E. S.; Chesebro, B. B.; Kabat, D. D. Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1 J. Virol. 1998, 72, 2855-2864